The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2022 | Standard surgical treatment for rectal adenocarcinoma: from TME to CRT-TEM

Name: Standard surgical treatment for rectal adenocarcinoma: from TME to CRT-TEM
Uploaded: 2022-06-05T00:00:00Z
Duration: 37 s
Description: Xavier Serra-Aracil, MD, PhD, Parc Tauli University Hospital, Barcelona, Spain, provides and overview of the standard surgical treatment of rectal adenocarcinoma, total mesorectal excision (TME). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Xavier Serra-Aracil • 5 Jun 2022

ASCO 2022

Gastrointestinal Cancer Rectal Cancer

Xavier Serra-Aracil, MD, PhD, Parc Tauli University Hospital, Barcelona, Spain, provides and overview of the standard surgical treatment of rectal adenocarcinoma, total mesorectal excision (TME). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.